VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 41 filers reported holding VIRACTA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $374,995 | -46.7% | 689,709 | 0.0% | 0.08% | -28.4% |
| Q1 2024 | $703,503 | +78.9% | 689,709 | 0.0% | 0.11% | +78.7% |
| Q4 2023 | $393,134 | -45.2% | 689,709 | 0.0% | 0.06% | -72.3% |
| Q3 2023 | $717,297 | -26.2% | 689,709 | 0.0% | 0.22% | +28.7% |
| Q2 2023 | $972,490 | -11.3% | 689,709 | 0.0% | 0.17% | -24.7% |
| Q1 2023 | $1,096,637 | +8.9% | 689,709 | 0.0% | 0.23% | +4.6% |
| Q4 2022 | $1,006,975 | -65.8% | 689,709 | 0.0% | 0.22% | -68.4% |
| Q3 2022 | $2,945,000 | +10.1% | 689,709 | 0.0% | 0.69% | -3.6% |
| Q2 2022 | $2,676,000 | -20.9% | 689,709 | -3.0% | 0.71% | -16.3% |
| Q1 2022 | $3,385,000 | +30.4% | 711,039 | 0.0% | 0.85% | +69.4% |
| Q4 2021 | $2,595,000 | -54.5% | 711,039 | 0.0% | 0.50% | -43.8% |
| Q3 2021 | $5,703,000 | -29.3% | 711,039 | 0.0% | 0.90% | -10.1% |
| Q2 2021 | $8,063,000 | +4.8% | 711,039 | -14.5% | 1.00% | -29.9% |
| Q1 2021 | $7,693,000 | – | 831,625 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 288,571 | $421,314 | 0.28% |
| BVF INC/IL | 3,614,662 | $5,277,407 | 0.22% |
| Samsara BioCapital, LLC | 689,709 | $1,006,975 | 0.22% |
| Rubric Capital Management LP | 1,330,983 | $1,943,235 | 0.08% |
| HAMILTON LANE ADVISORS LLC | 35,791 | $52 | 0.02% |
| MAI Capital Management | 426,916 | $623,297 | 0.01% |
| Jasper Ridge Partners, L.P. | 92,939 | $135,691 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 17,500 | $25,550 | 0.01% |
| RP Management, LLC | 3,700 | $5,402 | 0.01% |
| Laurion Capital Management LP | 698,000 | $1,019,080 | 0.01% |